𝔖 Bobbio Scriptorium
✦   LIBER   ✦

[Recent Results in Cancer Research] Angiogenesis Inhibition Volume 180 || Angiogenesis Inhibition in Cancer Therapy

✍ Scribed by Liersch, Rüdiger; Berdel, Wolfgang E.; Kessler, Torsten


Book ID
120208365
Publisher
Springer Berlin Heidelberg
Year
2009
Weight
858 KB
Category
Article
ISBN
3540782818

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


[Recent Results in Cancer Research] Angi
✍ Liersch, Rüdiger; Berdel, Wolfgang E.; Kessler, Torsten 📂 Article 📅 2009 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 573 KB

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and

[Recent Results in Cancer Research] Angi
✍ Liersch, Rüdiger; Berdel, Wolfgang E.; Kessler, Torsten 📂 Article 📅 2009 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 657 KB

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and

[Recent Results in Cancer Research] Angi
✍ Liersch, Rüdiger; Berdel, Wolfgang E.; Kessler, Torsten 📂 Article 📅 2009 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 572 KB

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and

[Recent Results in Cancer Research] Angi
✍ Liersch, Rüdiger; Berdel, Wolfgang E.; Kessler, Torsten 📂 Article 📅 2009 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 662 KB

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and